Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer.
Saved in:
| Title: | Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer. |
|---|---|
| Authors: | Linde C; Department of Pharmaceutics, University of Washington, Seattle, WA, United States., Chien YT; Department of Pharmaceutics, University of Washington, Seattle, WA, United States., Chen Z; Department of Pharmaceutics, University of Washington, Seattle, WA, United States., Mu Q; Department of Pharmaceutics, University of Washington, Seattle, WA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2024 May 02; Vol. 14, pp. 1393492. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
